<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02879331</url>
  </required_header>
  <id_info>
    <org_study_id>EC 33-16/IIS-FJD</org_study_id>
    <nct_id>NCT02879331</nct_id>
  </id_info>
  <brief_title>Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils</brief_title>
  <acronym>CYCLONE</acronym>
  <official_title>Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesis is that patients with homogeneous emphysema behave differently compared
      to heterogeneous emphysema with respect to exercise capacity. A better understanding of this
      difference will allow the investigators to choose the best treatment for each type of
      patient.

      The main purpose of this study is to evaluate the change in exercise capacity measured by
      cycle ergometry in patients with severe emphysema after endoscopic lung volume reduction with
      coils (eLVR).

      As a secondary purpose, the investigators want to perform an exploratory, randomized study to
      compare the results of two different therapeutic approaches in a small sample of patients
      with homogeneous emphysema.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study plans to include patients with severe emphysema candidates to go through eLVR with
      coils that fulfill all inclusion criteria and none of the exclusion criteria. Patients with
      both homogeneous and heterogeneous emphysema will be included.

      The main study intervention is the performance of a cyclo ergometry (not included in daily
      clinical practice) before (basal) and 6 months after going through the eLVR with coils.

      The subgroup of patients with homogeneous emphysema will be randomly assigned to the
      following therapeutic approaches:

        -  Group A: treatment with 10 coils in upper lobes

        -  Group B: treatment with 15 coils spared in upper and lower lobes

      Thus, the study includes:

        -  for all patients, the performance of two cycloergometries, before and 6 months after the
           eLVR

        -  Also, for the subset of homogeneous emphysema patients, an open label, randomized,
           parallel, two arm exploratory clinical trial.

      Sample size has not been formally calculated as there are no previous available data for the
      primary endpoint (change inspiratory capacity). Thus, 35 patients will be included according
      to the expected number of patients. Recruitment period will be 24 months and patient follow
      up will be 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Inspiratory Capacity (L)</measure>
    <time_frame>three months before procedure and six months after first procedure</time_frame>
    <description>Change in Inspiratory Capacity (L) at 6 months from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RV (L)</measure>
    <time_frame>three months before procedure and six months after first procedure</time_frame>
    <description>Residual Volume (L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-MWT (m)</measure>
    <time_frame>three months before procedure and six months after first procedure</time_frame>
    <description>Six minute walk test (m)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SGQLT (measured in points)</measure>
    <time_frame>three months before procedure and six months after first procedure</time_frame>
    <description>Saint George quality of life test (points)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FEV1(measured in liters)</measure>
    <time_frame>three months before procedure and six months after first procedure</time_frame>
    <description>Forced Expiratory Volume in 1 Second (L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FVC (measured in liters)</measure>
    <time_frame>three months before procedure and six months after first procedure</time_frame>
    <description>Forced Vital Capacity (L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoscopic Volume Reduction-Associated Complications Rate</measure>
    <time_frame>6 months</time_frame>
    <description>Endoscopic Volume Reduction Complications Rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cycloergometry-associated Complications Rate</measure>
    <time_frame>6 months</time_frame>
    <description>Cycloergometry-associated Complications Rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Pulmonary Emphysema</condition>
  <arm_group>
    <arm_group_label>10 coils in upper lobes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 coils in upper lobes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>15 coils in upper and lower lobes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 coils in upper and lower lobes</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>10 coils in upper lobes</intervention_name>
    <arm_group_label>10 coils in upper lobes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>15 coils in upper and lower lobes</intervention_name>
    <arm_group_label>15 coils in upper and lower lobes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cycloergometry</intervention_name>
    <arm_group_label>10 coils in upper lobes</arm_group_label>
    <arm_group_label>15 coils in upper and lower lobes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Emphysematous patient

          -  FEV1 &lt; 50%

          -  RV &gt; 200%

          -  Diffusion &lt;60% &gt;20%

          -  PSP &lt;55 mmHg

        Exclusion Criteria:

          -  Anticoagulants/antiplatelets

          -  Giant bullae (&gt; 8 cm , 1/3 hemithorax)

          -  More tan three moderate/severe exacerbation per year

          -  Negative to sign informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iker Fernandez-Navamuel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>FJD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lucia Llanos, MD, PhD</last_name>
    <phone>915504800</phone>
    <phone_ext>3144</phone_ext>
    <email>luciallanos@fjd.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Javier Flandes, MD, PhD</last_name>
    <phone>915504813</phone>
    <phone_ext>3543</phone_ext>
    <email>iferbas@fjd.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fundación Jiménez Díaz</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iker Fernandez-Navamuel, MD, PhD</last_name>
      <phone>915504800</phone>
      <phone_ext>3543</phone_ext>
      <email>iferbas@fjd.es</email>
    </contact>
    <contact_backup>
      <last_name>Javier Flandes, MD, PhD</last_name>
      <phone>915504800</phone>
      <phone_ext>3543</phone_ext>
      <email>jflandes@fjd.es</email>
    </contact_backup>
    <investigator>
      <last_name>Iker Fernandez-Navamuel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Javier Flandes, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Jesús Rodriguez, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Álvarez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucía Llanos, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ignacio Mahillo, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Hartman JE, Klooster K, Ten Hacken NH, Slebos DJ. Treatment of emphysema using bronchoscopic lung volume reduction coil technology: an update on efficacy and safety. Ther Adv Respir Dis. 2015 Oct;9(5):251-9. doi: 10.1177/1753465815589904. Epub 2015 Jun 25. Review.</citation>
    <PMID>26113524</PMID>
  </reference>
  <reference>
    <citation>Deslee G, Klooster K, Hetzel M, Stanzel F, Kessler R, Marquette CH, Witt C, Blaas S, Gesierich W, Herth FJ, Hetzel J, van Rikxoort EM, Slebos DJ. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax. 2014 Nov;69(11):980-6. doi: 10.1136/thoraxjnl-2014-205221. Epub 2014 Jun 2.</citation>
    <PMID>24891327</PMID>
  </reference>
  <reference>
    <citation>Boutou AK, Zoumot Z, Nair A, Davey C, Hansell DM, Jamurtas A, Polkey MI, Hopkinson NS. The Impact of Homogeneous Versus Heterogeneous Emphysema on Dynamic Hyperinflation in Patients With Severe COPD Assessed for Lung Volume Reduction. COPD. 2015;12(6):598-605. doi: 10.3109/15412555.2015.1020149. Epub 2015 Sep 23.</citation>
    <PMID>26398112</PMID>
  </reference>
  <reference>
    <citation>Arós F, Boraita A, Alegría E, Alonso AM, Bardají A, Lamiel R, Luengo E, Rabadán M, Alijarde M, Aznar J, Baño A, Cabañero M, Calderón C, Camprubí M, Candell J, Crespo M, de la Morena G, Fernández A, Ferrero JA, Gayán R, Bolao IG, Hernández M, Maceira A, Marín E, Muela de Lara A, Placer L, San Román JA, Serratosa L, Sosa V, Subirana MT, Wilke M. [Guidelines of the Spanish Society of Cardiology for clinical practice in exercise testing]. Rev Esp Cardiol. 2000 Aug;53(8):1063-94. Spanish.</citation>
    <PMID>10956604</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2016</study_first_posted>
  <last_update_submitted>September 14, 2017</last_update_submitted>
  <last_update_submitted_qc>September 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pulmonary emphysema</keyword>
  <keyword>coils</keyword>
  <keyword>cycloergometry</keyword>
  <keyword>lung volume reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

